SCHEMBL10179802

SCHEMBL10179802

CC(C)OC(=O)c1cc(I)cc(I)c1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
COMT P21964 1/20 0.40
ALDH1A1 P00352 6/20 0.39
NPC1 O15118 3/20 0.39
RECQL P46063 1/20 0.39
CA12 O43570 6/20 0.39
CA1 P00915 6/20 0.39
CA2 P00918 6/20 0.39
CA7 P43166 6/20 0.39
CA9 Q16790 6/20 0.39
CA14 Q9ULX7 6/20 0.39
KDM4E B2RXH2 5/20 0.36
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
TP53 P04637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10180003 0.83 SMN1; SMN2 (0.42) COMTALDH1A1CA12CA1CA2
SCHEMBL28035660 0.81 ALDH1A1 (0.38) CRHBPCRHR2COMTALDH1A1NPC1
SCHEMBL28035661 0.81 MEN1 (0.31) COMTLMNAHTTPKMMEN1
SCHEMBL10179559 0.79 ALDH1A1 (0.46) ALDH1A1NPC1CA12CA1CA2
SCHEMBL10180438 0.76 PKM (0.45) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL10179930 0.69 HTT (0.32) MAPTLMNAHTTMEN1KMT2A
SCHEMBL27300584 0.69 MEN1 (0.56) CRHBPCRHR2ALDH1A1NPC1RECQL
SCHEMBL9321923 0.68 CRHBP (0.46) CRHBPCRHR2COMTALDH1A1NPC1
SCHEMBL17707769 0.68 CRHBP (0.46) CRHBPCRHR2COMTALDH1A1NPC1
SCHEMBL11616565 0.68 ALDH1A1 (0.44) COMTALDH1A1KDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2474536-B1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF IHARA CHEMICAL IND CO (JP) 2014-06-25 EP disclosed
US-20120178931-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF IHARA CHEMICAL INDUSTRY CO., LTD (JP) 2012-07-12 US disclosed
EP-2474536-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF Ihara Chemical Industry Co., Ltd. (JP) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178931-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF DPYD, UMPS, PNP CRHBP 3676/4885CRHR2 4334/4885COMT 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.